Fintel reports that on December 17, 2024, Morgan Stanley upgraded their outlook for Quest Diagnostics (NYSE:DGX) from ...

Morgan Stanley upgraded Quest Diagnostics (DGX) to Overweight from Equal Weight with a price target of $172, up from $145. The firm sees ...

BofA raised the firm’s price target on Quest Diagnostics (DGX) to $182 from $179 and keeps a Buy rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma and Biotech ...

Quest Diagnostics Inc. closed $9.25 below its 52-week high ($165.32), which the company achieved on November 25th.

I ordered a test online. Then I went into the Quest office for my appointment and there was a sign on the wall that said no tests without a dr. order. No one was in the office. I didn't have a dr ...

If you’re new to the Meta Quest 3 or the Meta Quest 3S, there’s a huge world out/in there, but getting started can be a challenge, so I put together a collection of must-haves for "3 series ...

The stock's fall snapped a two-day winning streak.

Looking to get into virtual reality? Meta Quest 3 represents a significant step forward in virtual reality (VR) and a great starting point for everyone. The newly unveiled Meta Quest 3S also ...

After finally building the type of platform required to belatedly seize control in this series, the hosts steadily reverted to type on the opening day of the third test at Seddon Park. Playing to ...